• ICU Management & Practice 2021 Subject Index

    Issues/ Pages Volume 21, Issue 1  1-60   https://iii.hm/17iz Volume 21, Issue 2  61-116  https://iii.hm/18zj   Volume 21, Issue 3  117-168   https://iii.hm/1afx Volume 21, Issue 4  169-202   https://iii.hm/1bky Volume 21, Issue 5  203-249   https://iii.hm/1c7q Volume 21, Issue 6  250-302

    READ MORE
  • ICU Management & Practice 2021 Author Index

    Aarab Y  20   https://iii.hm/17j3 ,  162   https://iii.hm/1agk Allen J  52   https://iii.hm/17jm Artigas A  70   https://iii.hm/18so ,  174  https://iii.hm/1bk3 ,  176   https://iii.hm/1bk5 Banner-Goodspeed V  93   https://iii.hm/18sw Bautista-Aguilar GA  229  https://iii.hm/1

    READ MORE
  • Clinical Haematology

    P atients in the intensive care unit frequently report haematological issues. These issues are often a result of critical illness. The most common haematological complications seen in the ICU include thrombocytopenia, anaemia, leukocytosis, thrombocytosis, and coagulopathies. In addition, emergencies in malignant haematology are commonly seen in...

    READ MORE
  • Anaemia in the Critically Ill: What is the Major Culprit?

    Anaemia is commonly encountered in the critically ill and is associated with poor outcomes. The cause is multifactorial and includes high hepcidin levels and a blunted response to erythropoietin. A naemia is defined by haemoglobin (Hb) < 12 g/dL for women and Hb below 13 g/dL for men, according to the WHO (1968). Anaemia is a prevalent...

    READ MORE
  • Management of Pulmonary Embolism in the Intensive Care Unit

    Pulmonary embolism is a reason for admission to the Intensive Care Unit and this complication in hospitalised patients is associated with high morbidity and mortality. The identification and management of pulmonary embolism is a challenge for doctors. Introduction Pulmonary Embolism (PE) is the third c ardiovascular cause of death since...

    READ MORE
  • Emergencies in Malignant Haematology for the Intensivist

    An overview of emergencies that are commonly seen in malignant haematology, side effects of novel therapies, and complications of allogeneic haematologic stem cell transplant. Introduction Critical illness is common in patients with haematologic malignancies. Recent data demonstrate that 14% of patients will require ICU admission...

    READ MORE
  • CAR-T Cell Therapy – What An Intensivist Should Know

    CAR-T therapy is a promising treatment for B-cell malignancies but is also associated with toxicities such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Frequent monitoring, timely recognition and prompt management in ICU are paramount to ensure good outcomes. Introduction...

    READ MORE
  • Indirect Calorimetry in Mechanically Ventilated Patients to Assess Nutritional Targets

    An overview of the physiological aspects of indirect calorimetry, its limitations in use, the available literature and future prospects for tailored nutrition. Introduction Medical nutrition therapy (MNT) is an essential part of patient care in the intensive care unit (ICU) setting. Similar to mechanical ventilation and haemodynamic...

    READ MORE
  • The Importance of Accurate Glucose Monitoring in Critically Ill Patients

    The complexity of glucose testing, the limitations of point-of-care blood glucose monitoring systems and the need for accuracy and reliability to ensure optimised patient outcomes. C ritically ill patients are not found just in intensive care units, but throughout the hospital: emergency departments, post-anaesthesia care units,...

    READ MORE
  • Agenda

    DECEMBER 1-3   DIVI 2021 - German Interdisciplinary Association for Intensive Care and Emergency Medicine Congress Virtual event https://iii.hm/1dcs 5-8  Critical Care Canada Forum 2021 Virtual event https://iii.hm/1dct 6-8   ICS State of the Art 2021 Virtual event https://iii.hm/1dcu 17-19 ...

    READ MORE
Subscribe To HealthManagement